BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 25233195)

  • 21. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
    Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
    Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study.
    Hu Y; Xu C; Xu B; Hu L; Liu Q; Chen J; Liu J; Liu L; Yang J; Chen T; Wen J; Jiang N; Zhang Y; Cao M; Feng J; Lin X; Wang Z; Xu B; Zhou YH
    J Viral Hepat; 2018 Apr; 25(4):429-437. PubMed ID: 29193547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
    Han L; Zhang HW; Xie JX; Zhang Q; Wang HY; Cao GW
    World J Gastroenterol; 2011 Oct; 17(38):4321-33. PubMed ID: 22090789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-Child Transmission.
    Chamroonkul N; Piratvisuth T
    Paediatr Drugs; 2017 Jun; 19(3):173-181. PubMed ID: 28434087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
    [No Abstract]   [Full Text] [Related]  

  • 26. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
    Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
    Wang J; Liu J; Qi C; Yan T; Cao F; Jin L; He Y; Yang Y; Zhang S; Chen T; Zhao Y
    Antivir Ther; 2015; 20(7):681-7. PubMed ID: 26215771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental Consequences of Prenatal Telbivudine Exposure during the Third Trimester.
    Pan CQ; Li MH; Zeng HH; Zhang Y; Cao WH; Wang Y; Zhou MF; Hu YH; Wan G; Xie Y; Yi W
    Clin Gastroenterol Hepatol; 2021 May; 19(5):1061-1063. PubMed ID: 32371166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis.
    Deng M; Zhou X; Gao S; Yang SG; Wang B; Chen HZ; Ruan B
    Virol J; 2012 Sep; 9():185. PubMed ID: 22947333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The safety of telbivudine in preventing mother-to-infant transmission of hepatitis B virus in pregnant women after discontinuation].
    Deng Y; Wu W; Zhang D; Hu P; Kang J; Yang Y; Zeng W
    Zhonghua Gan Zang Bing Za Zhi; 2015 Aug; 23(8):586-9. PubMed ID: 26447621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of telbivudine in pregnant women to prevent perinatal transmission of hepatitis B virus].
    Han GR; Jiang HX; Wang GJ; Yue X; Wang CM; Kan NY; Wu MM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):201-5. PubMed ID: 22475140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral antiviral drugs to prevent mother-to-child transmission of hepatitis B virus: a network meta-analysis.
    Jia F; Deng F; Tong S; Li S; Ren H; Yin W
    Hepatol Int; 2020 May; 14(3):338-346. PubMed ID: 32130674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course and perinatal transmission of chronic hepatitis B during pregnancy: A real-world prospective cohort study.
    Chen ZX; Gu GF; Bian ZL; Cai WH; Shen Y; Hao YL; Zhang S; Shao JG; Qin G
    J Infect; 2017 Aug; 75(2):146-154. PubMed ID: 28551372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus.
    Chen HL; Lee CN; Chang CH; Ni YH; Shyu MK; Chen SM; Hu JJ; Lin HH; Zhao LL; Mu SC; Lai MW; Lee CL; Lin HM; Tsai MS; Hsu JJ; Chen DS; Chan KA; Chang MH; ;
    Hepatology; 2015 Aug; 62(2):375-86. PubMed ID: 25851052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region.
    Samadi Kochaksaraei G; Castillo E; Osman M; Simmonds K; Scott AN; Oshiomogho JI; Lee SS; Myers RP; Martin SR; Coffin CS
    J Viral Hepat; 2016 Jan; 23(1):15-22. PubMed ID: 26192022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.
    Gao X; Duan X; Cai H; Hu Y; Liu M; Kang K; Zhou M; Fu D; Yi W
    Eur J Gastroenterol Hepatol; 2020 Dec; 32(12):1533-1537. PubMed ID: 31895914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus: a meta-analysis].
    Xu HX; Wang LJ; Yu YX; Wu YP; Xu YF; Liu XX; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):755-60. PubMed ID: 23207336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.